Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

Anja Strangfeld*, Franka Hierse, Rolf Rau, Gerd-Ruediger Burmester, Brigitte Krummel-Lorenz, Winfried Demary, Joachim Listing and Angela Zink

Arthritis Research & Therapy 2010, 12:R5 doi:10.1186/ar2904

Accesses  

  • Last 30 days: 165 accesses
  • Last 365 days: 1590 accesses
  • All time: 4899 accesses

Cited by